Toulouse Cedex 9

• ABTECT-Maintenance – ABX464 Treatment Evaluation for ulcerative Colitis Therapy Not authorised
  2022-500537-84-00 5 Moderately to severely active ulcerative colitis
• A phase II study evaluating the efficacy and safety of IMetelstat in Patients with HR myElodysplastic SyndromeS or AML failing HMA-based the … Not authorised
  2022-500721-32-00 4 AML and MDS patients failing or being refractory to hypomethylating ag
• Clinical trial of MK-7648A in adults and children with skin cancer Not authorised
  2022-501417-31-00 5 High-risk Resected Melanoma
• PROSTABACT : Relevance of the treatment with antibiotics before endoscopic surgery of lower urinary symptoms related to prostate hypertrophy … Not authorised
  2023-510191-31-00 5 Benign Prostate Hyperplasia
• Effect of Copper CU64 PSMA I&T scanning to detect potential disease spread to lymph nodes in men with newly diagnosed Prostate Cancer Not authorised
  2024-512754-16-00 5 Prostate cancer
• Evaluate the efficacy of 12-month neoadjuvant chemotherapy in terms of disease-free survival in patients with localized digestive neuroendoc … Not authorised
  2024-515603-19-00 4 Localized digestive Neuroendocrine Carcinomas
• A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM 201 in Naïve-to-Tr … Not authorised
  2025-523820-26-00 5 Growth Hormone Deficiency (GHD)
• A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluat … Pending
  2022-502365-26-00 5 Asthma
• Fecal microbiota transplantation for primary sclerosing cholangitis - randomized study versus sham transplantation (FMT-SCLER). Pending
  2023-505469-95-00 10 Primary Sclerosing Cholangitis
• Efficacy and safety of zoledronate versus placebo on pain at week 12 in pediatric patients with chronic recurrent multifocal osteomyelitis r … Pending
  2023-506420-93-00 4 Chronic recurrent multifocal osteomyelitis (CRMO)
• Pulse corticosteroids or/and Immunoglobulins to treat fulminant Myocarditis: a double-blind randomized controlled adaptive trial (The CORIUM … Pending
  2023-506599-28-01 4 Fulminant myocarditis
• Efficacy and tolerance of nicotinamide supplementation during acute kidney injury: a prospective randomized double-blind trial Pending
  2023-508664-30-00 5 Acute kidney injury
• Corticoid Therapy in Acute Myocarditis Pending
  2024-510602-90-00 5 Patients presenting with acute myocarditis proven by cardiac magnetic
• A first-in-human, open-label, clinical study to assess the safety, tolerability, and activity of OT-C001 (amplified/activated allogenic natu … Pending
  2024-511843-24-00 1 Relapsed/refractory (R/R) diffuse large B-cell lymphoma
• Safety study for the use of Rapamycin in children with familial adenomatous polyposis - RAPA-4-FAP Pending
  2024-512079-11-00 4 Familial adenomatous polyposis
• SPARE : Stopping Pneumonia Antibiotherapy Regimen Early Pending
  2024-512236-30-00 5 Community-acquired alveolar pneumonia in children
• Extension Study of ACT-EARLY Pending
  2024-513676-18-00 5 Transthyretin Amyloidosis
• SIOP PNET 5 medulloblastoma Pending
  2024-513724-42-00 10 Medulloblastoma
• MInimal residual Disease Adapted Strategy / IFM 2020-02 Pending
  2024-513889-19-00 5 Multiple Myeloma
• CANDISHORT : A randomized study of a short duration therapy for candidemia Pending
  2024-514244-81-00 5 Uncomplicated candidemia
• Ketamine infusion for symptomatological improvement of severe borderline personality disorder: a pilot study Pending
  2024-514361-19-00 4 borderline personality disorder
• Comparison of azathioprine to methotrexate in combination therapy with adalimumab in Crohn’s Disease: an open-label randomized controlled tr … Pending
  2024-514633-38-00 5 Crohn’s Disease
• FirST lines of biologics in pAtients with ulceRaTivE colitis: a Randomised controlled trial Pending
  2024-514964-24-00 5 ulcerative colitis
• ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoi … Pending
  2024-515107-19-00 5 Patients (male or female) ≥18 years old with Detrusor overactivity (DO

Showing 1–24 of 893 trials